Electronic Aspirin

For people who suffer from migraines, cluster headaches, and other causes of chronic, excruciating head or facial pain, the wrong popular method of "take two aspirins and call me in the morning" is useless. Doctors have long associated the most severe, chronic forms of headache with the sphenopalatine ganglion (SPG), facial nerve bundle, but haven't yet found a treatment that works on the SPG long-term. Electronic aspirin is a patient-powered tool for blocking SPG signals at the first sign of a headache. The system functions by implanting a small nerve stimulating device in the upper gum on the side of the head that is affected by headache. The lead tip of the implant connects with the SPG bundle, and when a patient senses the onset of a headache, he or she places a handheld remote controller on the cheek nearest the implant. The resulting signals stimulate the SPG nerves and block the pain-causing neurotransmitters.

Needle-Free Diabetes Care

Diabetes self-care is pain—literally. It brings the continual need to draw blood for glucose testing, insulin shots are needed every day and the heightened risk of infection from all that poking. The best options for automating most of the complicated daily process of blood sugar management are continuous glucose monitors and insulin pumps– but they don't completely remove the need for skin pricks and shots-. But there's new skin in this game. Echo Therapeutics  is an improved technology that would replace the poke with a patch. The company is working on a transdermal biosensor that avoids the drawing of blood and able to read blood analytes through skin in creative ways. The technology involves a handheld electric-toothbrush-like device that removes just enough top-layer skin cells to put the patient's blood chemistry within signal range of a patch-borne biosensor. The sensor collects one reading per minute and sends the data wirelessly to a remote monitor, triggering audible alarms when levels go out of the patient's optimal range and tracking glucose levels over time.

Robotic Check-Ups

A pillar of health reform is enhancing the access to a better health care for more people. Technology affects the cost and increasingly potent means to connect clinics in the vast and medically underserved rural regions of the United States with big city medical centers and their specialists. Telemedicine is well established as a tool for triage and assessment in emergencies, but new medical robots are one step ahead—they can now patrol hospital hallways on more routine rounds, checking on patients in different rooms and managing their individual charts and vital signs without direct human intervention. The RP-VITA Remote Presence Robot produced jointly by iRobot Corp. and InTouch Health is the first such autonomous navigation remote-presence robot to receive FDA clearance for hospital use. The device is a mobile cart with a two-way video screen and medical monitoring equipment, programmed to maneuver through the busy halls of a hospital.

A Valve Job with Heart

The Sapien transcatheter aortic valve is life-saving alternative to open-heart surgery for patients who need a new valve but can't endure the rigors of the operation. Manufactured by Edwards Life Sciences , the Sapien has been available in Europe for some time but is only now finding its first use in U.S. heart centers—where it is limited only to the frailest patients thus far. The Sapien valve is guided through the femoral artery by catheter from a small incision near the grown or rib cage. The valve material is made of bovine tissue attached to a stainless-steel stent, which is expanded by inflating a small balloon when correctly placed in the valve space. A simpler procedure that promises dramatically shorter hospitalizations is bound to have a positive effect on the cost of care.

Cutting Back on Melanoma Biopsies

A large number of dangerous-looking moles are actually harmless, melanoma, almost the most cancer causes deaths among others.

, an invasive surgical biopsy is the only way to know for sure. Today dermatologists got a trustier method to make the right call — a handheld tool approved by the FDA for multispectral analysis of tissue morphology. The MelaFind optical scanner lightens the doctors to whether biopsy is needed or not rather than being a definitive diagnosis. This method helps reducing the number of patients that being left with unnecessary biopsy scars.  Also, it saves a huge amount of money by elimination of unnecessary procedures. The MelaFind technology uses missile navigation technologies to optically scan the surface of a suspicious lesion at 10 electromagnetic wavelengths. The collected signals are processed by heavy-duty algorithms and matched against a registry of 10,000 digital images of melanoma and skin disease.